JP2011513728A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011513728A5 JP2011513728A5 JP2010548752A JP2010548752A JP2011513728A5 JP 2011513728 A5 JP2011513728 A5 JP 2011513728A5 JP 2010548752 A JP2010548752 A JP 2010548752A JP 2010548752 A JP2010548752 A JP 2010548752A JP 2011513728 A5 JP2011513728 A5 JP 2011513728A5
- Authority
- JP
- Japan
- Prior art keywords
- spectrum
- ranges
- patient
- mass spectrum
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/321,393 | 2009-01-20 | ||
| US12/321,393 US7867775B2 (en) | 2006-03-31 | 2009-01-20 | Selection of head and neck cancer patients for treatment with drugs targeting EGFR pathway |
| PCT/US2009/006269 WO2010085235A1 (en) | 2009-01-20 | 2009-11-20 | Selection of head and neck cancer patients for treatment with drugs targeting egfr pathway |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011513728A JP2011513728A (ja) | 2011-04-28 |
| JP2011513728A5 true JP2011513728A5 (enExample) | 2012-03-01 |
| JP5025802B2 JP5025802B2 (ja) | 2012-09-12 |
Family
ID=41559566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010548752A Expired - Fee Related JP5025802B2 (ja) | 2009-01-20 | 2009-11-20 | Ｅｇｆｒ経路を標的化する薬物による治療のための頭頸部癌患者の選択 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7867775B2 (enExample) |
| EP (1) | EP2247954B1 (enExample) |
| JP (1) | JP5025802B2 (enExample) |
| KR (1) | KR101131309B1 (enExample) |
| AT (1) | ATE516503T1 (enExample) |
| AU (1) | AU2009338174B2 (enExample) |
| CA (1) | CA2718113A1 (enExample) |
| ES (1) | ES2368784T3 (enExample) |
| IL (1) | IL211943A (enExample) |
| TW (1) | TWI368737B (enExample) |
| WO (1) | WO2010085235A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7736905B2 (en) | 2006-03-31 | 2010-06-15 | Biodesix, Inc. | Method and system for determining whether a drug will be effective on a patient with a disease |
| US7906342B2 (en) * | 2006-03-31 | 2011-03-15 | Biodesix, Inc. | Monitoring treatment of cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples |
| US7867775B2 (en) * | 2006-03-31 | 2011-01-11 | Biodesix, Inc. | Selection of head and neck cancer patients for treatment with drugs targeting EGFR pathway |
| KR101556726B1 (ko) * | 2010-02-24 | 2015-10-02 | 바이오디식스, 인크. | 질량스펙트럼 분석을 이용한 치료제 투여를 위한 암 환자 선별 |
| US8914238B2 (en) | 2011-01-28 | 2014-12-16 | Biodesix, Inc. | Method for predicting breast cancer patient response to endocrine therapy |
| KR102103319B1 (ko) | 2012-06-26 | 2020-04-22 | 바이오디식스, 인크. | 면역반응 발생 요법으로 치료하기 위해 암환자들의 선택, 및 선택해제를 위한 질량-스펙트럼법 |
| US8718996B2 (en) | 2012-07-05 | 2014-05-06 | Biodesix, Inc. | Method for predicting whether a cancer patient will not benefit from platinum-based chemotherapy agents |
| US10037874B2 (en) | 2014-12-03 | 2018-07-31 | Biodesix, Inc. | Early detection of hepatocellular carcinoma in high risk populations using MALDI-TOF mass spectrometry |
| CN112710723B (zh) | 2015-07-13 | 2024-11-12 | 佰欧迪塞克斯公司 | 受益于pd-1抗体药物的肺癌患者的预测性测试和分类器开发方法 |
| WO2017136139A1 (en) | 2016-02-01 | 2017-08-10 | Biodesix, Inc. | Predictive test for melanoma patient benefit from interleukin-2 (il2) therapy |
| WO2017176423A1 (en) | 2016-04-08 | 2017-10-12 | Biodesix, Inc. | Classifier generation methods and predictive test for ovarian cancer patient prognosis under platinum chemotherapy |
| WO2018129301A1 (en) | 2017-01-05 | 2018-07-12 | Biodesix, Inc. | Method for identification of cancer patients with durable benefit from immunotherapy in overall poor prognosis subgroups |
| EP3665199A4 (en) | 2017-08-07 | 2021-08-11 | Genecentric Therapeutics, Inc. | METHOD OF SUBTYPING PLATE EPITHELIAL CARCINOMA OF THE HEAD AND NECK |
| US20210074431A1 (en) * | 2017-08-30 | 2021-03-11 | Genecentric Therapeutics, Inc. | Gene expression subtype analysis of head and neck squamous cell carcinoma for treatment management |
| EP3773691A4 (en) | 2018-03-29 | 2022-06-15 | Biodesix, Inc. | DEVICE AND METHOD FOR IDENTIFICATION OF PRIMARY IMMUNORESISTANCE IN CANCER PATIENTS |
| WO2022084993A1 (en) * | 2020-10-19 | 2022-04-28 | B. G. Negev Technologies And Applications Ltd., At Ben-Gurion University | Rapid and direct identification and determination of urine bacterial susceptibility to antibiotics |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60332639D1 (de) | 2002-08-06 | 2010-07-01 | Univ Johns Hopkins | Verwendung von biomarkern zum nachweis von eierstockkrebs |
| JP2007506442A (ja) | 2003-05-30 | 2007-03-22 | ゲノミック ヘルス， インコーポレイテッド | Ｅｇｆｒ阻害薬への応答に関する遺伝子発現マーカー |
| US20050267689A1 (en) | 2003-07-07 | 2005-12-01 | Maxim Tsypin | Method to automatically identify peak and monoisotopic peaks in mass spectral data for biomolecular applications |
| US20050048547A1 (en) | 2003-07-17 | 2005-03-03 | Hongyu Zhao | Classification of disease states using mass spectrometry data |
| WO2005098445A2 (en) | 2004-03-30 | 2005-10-20 | Eastern Virginia Medical School | Lung cancer biomarkers |
| EP2439284B1 (en) * | 2004-03-31 | 2019-05-08 | The General Hospital Corporation | Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments |
| US20060029574A1 (en) | 2004-08-06 | 2006-02-09 | Board Of Regents, The University Of Texas System | Biomarkers for diagnosis, prognosis, monitoring, and treatment decisions for drug resistance and sensitivity |
| US7908091B2 (en) | 2006-03-17 | 2011-03-15 | Prometheus Laboratories Inc. | Methods of predicting and monitoring tyrosine kinase inhibitor therapy |
| US7736905B2 (en) * | 2006-03-31 | 2010-06-15 | Biodesix, Inc. | Method and system for determining whether a drug will be effective on a patient with a disease |
| US7867775B2 (en) | 2006-03-31 | 2011-01-11 | Biodesix, Inc. | Selection of head and neck cancer patients for treatment with drugs targeting EGFR pathway |
-
2009
- 2009-01-20 US US12/321,393 patent/US7867775B2/en not_active Expired - Lifetime
- 2009-11-20 AU AU2009338174A patent/AU2009338174B2/en not_active Ceased
- 2009-11-20 EP EP09774994A patent/EP2247954B1/en active Active
- 2009-11-20 WO PCT/US2009/006269 patent/WO2010085235A1/en not_active Ceased
- 2009-11-20 ES ES09774994T patent/ES2368784T3/es active Active
- 2009-11-20 KR KR1020107019382A patent/KR101131309B1/ko not_active Expired - Fee Related
- 2009-11-20 JP JP2010548752A patent/JP5025802B2/ja not_active Expired - Fee Related
- 2009-11-20 AT AT09774994T patent/ATE516503T1/de not_active IP Right Cessation
- 2009-11-20 CA CA2718113A patent/CA2718113A1/en not_active Abandoned
- 2009-12-16 TW TW098143182A patent/TWI368737B/zh not_active IP Right Cessation
-
2011
- 2011-03-24 IL IL211943A patent/IL211943A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012507033A5 (enExample) | ||
| Paraskevaidi et al. | Clinical applications of infrared and Raman spectroscopy in the fields of cancer and infectious diseases | |
| Shin et al. | Correlation between cancerous exosomes and protein markers based on surface-enhanced Raman spectroscopy (SERS) and principal component analysis (PCA) | |
| Moisoiu et al. | SERS-based differential diagnosis between multiple solid malignancies: Breast, colorectal, lung, ovarian and oral cancer | |
| CN101806740B (zh) | 一种人体血浆表面增强拉曼光谱结合主成分分析检测方法 | |
| Koopaie et al. | Salivary biomarkers in breast cancer diagnosis: a systematic review and diagnostic meta‐analysis | |
| Zhang et al. | Metabolomics for biomarker discovery: moving to the clinic | |
| JP5025802B2 (ja) | Ｅｇｆｒ経路を標的化する薬物による治療のための頭頸部癌患者の選択 | |
| JP2009534667A5 (enExample) | ||
| Vadala et al. | A review on electronic nose for diagnosis and monitoring treatment response in lung cancer | |
| Kang et al. | H-CNN combined with tissue Raman spectroscopy for cervical cancer detection | |
| Duffield et al. | Recent advances in SERS assays for detection of multiple extracellular vesicles biomarkers for cancer diagnosis | |
| Liu et al. | Label-free surface-enhanced Raman spectroscopy of serum based on multivariate statistical analysis for the diagnosis and staging of lung adenocarcinoma | |
| WO2007109881A8 (en) | Biomarkers useful for diagnosing prostate cancer, and methods thereof | |
| JP2011506917A5 (enExample) | ||
| JP2011516046A5 (enExample) | ||
| CN103954608A (zh) | 一种鉴定降糖中药中是否添加吡格列酮或罗格列酮的方法 | |
| CN101424661B (zh) | 一种活动性肺结核病的血清诊断模型的建立方法 | |
| WO2011037827A3 (en) | Identification of discriminant proteins through antibody profiling, methods and apparatus for identifying an individual | |
| Avram et al. | Recent advances in surface-enhanced Raman spectroscopy based liquid biopsy for colorectal cancer | |
| Purandare et al. | Infrared spectroscopy with multivariate analysis segregates low-grade cervical cytology based on likelihood to regress, remain static or progress | |
| Wang et al. | Integrated multi‐biofluid extracellular vesicle isolation with dual‐platform mass spectrometry metabolomics for prostate cancer detection | |
| Cao et al. | A potential method for non-invasive acute myocardial infarction detection based on saliva Raman spectroscopy and multivariate analysis | |
| Lin et al. | Blood surface-enhanced Raman spectroscopy based on Ag and Au nanoparticles for nasopharyngeal cancer detection | |
| CN115951067A (zh) | 一种膀胱癌生物标志物提取方法及膀胱癌诊断模型 |